Genetic manipulation of the cardiac mitochondrial phosphate carrier does not affect permeability transition

Journal of Molecular and Cellular Cardiology

Volumn 72, Issue , 2014, Pages 316-325

  Gutiérrez Aguilar, Manuel ^a   Douglas, Diana L ^a   Gibson, Anne K ^c   Domeier, Timothy L ^c   Molkentin, Jeffery D ^d,e   Baines, Christopher P ^a,b,c  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c University of Missouri   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

Cyclophilin D; Mitochondrial permeability transition; Mitochondrial phosphate carrier; Mouse genetics

Indexed keywords

ADENOSINE TRIPHOSPHATE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PHOSPHATE CARRIER; UNCLASSIFIED DRUG; CALCIUM; CARRIER PROTEIN; CYCLOPHILIN; CYCLOPHILIN D; PHOSPHATE TRANSPORTER; PROTEIN BINDING;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DOWN REGULATION; GENE OVEREXPRESSION; GENE SILENCING; HEART MITOCHONDRION; HEART MUSCLE OXYGEN CONSUMPTION; HEART SIZE; HEART VENTRICLE HYPERTROPHY; MITOCHONDRIAL PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN PROTEIN INTERACTION; SWELLING; TRANSGENIC MOUSE; UPREGULATION; ANIMAL; CARDIOMEGALY; CHEMICAL STRUCTURE; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; GENETICS; HEART MUSCLE; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE; MITOCHONDRION; OXYGEN CONSUMPTION; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; CARDIOMEGALY; CYCLOPHILINS; GENE EXPRESSION REGULATION; GENETIC ENGINEERING; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA; MITOCHONDRIAL MEMBRANE TRANSPORT PROTEINS; MITOCHONDRIAL MEMBRANES; MODELS, MOLECULAR; MYOCARDIUM; OXYGEN CONSUMPTION; PHOSPHATE TRANSPORT PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 84901359354     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.04.008     Document Type: Article

References (40)

1. Schriewer J.M., Peek C.B., Bass J., Schumacker P.T. ROS-mediated PARP activity undermines mitochondrial function after permeability transition pore opening during myocardial ischemia-reperfusion. J Am Heart Assoc 2013, 10.1161/JAHA.113.000159.
2. Lablanche S., Cottet-Rousselle C., Lamarche F., Benhamou P.-Y., Halimi S., Leverve X., et al. Protection of pancreatic INS-1 β-cells from glucose- and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin. Cell Death Dis 2011, 10.1038/cddis.2011.15.
3. Wallace D.C. Mitochondria and cancer. Nat Rev Cancer 2012, 12:685-698.
4. Baines C.P. The cardiac mitochondrion: nexus of stress. Annu Rev Physiol 2010, 72:61-80.
5. Brenner C., Moulin M. Physiological roles of the permeability transition pore. Circ Res 2012, 111:1237-1247.
6. Halestrap A.P. A pore way to die: the role of mitochondria in reperfusion injury and cardioprotection. Biochem Soc Trans 2010, 38:841.
7. Kokoszka J.E., Waymire K.G., Levy S.E., Sligh J.E., Cai J., Jones D.P., et al. The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 2004, 427:461-465.
8. Nakagawa T., Shimizu S., Watanabe T., Yamaguchi O., Otsu K., Yamagata H., et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 2005, 434:652-658.
9. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 2005, 434:658-662.
10. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., Bernardi P. Properties of the permeability transition pore in mitochondria devoid of cyclophilin D. J Biol Chem 2005, 280:18558-18561.
11. Giorgio V., Stockum Von S., Antoniel M., Fabbro A., Fogolari F., Forte M., et al. Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc Natl Acad Sci U S A 2013, 110:5887-5892.
12. Bonora M., Bononi A., De Marchi E., Giorgi C., Lebiedzinska M., Marchi S., et al. Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle 2013, 12:674-683.
13. Leung A.W.C., Halestrap A.P. Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim Biophys Acta 2008, 1777:946-952.
14. Leung A.W.C., Varanyuwatana P., Halestrap A.P. The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J Biol Chem 2008, 283:26312-26323.
15. Giorgio V., Bisetto E., Soriano M.E., Dabbeni-Sala F., Basso E., Petronilli V., et al. Cyclophilin D modulates mitochondrial F0F1-ATP synthase by interacting with the lateral stalk of the complex. J Biol Chem 2009, 284:33982-33988.
16. Kang B.H., Plescia J., Dohi T., Rosa J., Doxsey S.J., Altieri D.C. Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 2007, 131:257-270.
17. Eliseev R.A., Malecki J., Lester T., Zhang Y., Humphrey J., Gunter T.E. Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J Biol Chem 2009, 284:9692-9699.
18. McGee A.M., Baines C.P. Complement 1q-binding protein inhibits the mitochondrial permeability transition pore and protects against oxidative stress-induced death. Biochem J 2010, 433:119-125.
19. Mayr J.A., Merkel O., Kohlwein S.D., Gebhardt B.R., Bohles H., Fotschl U., et al. Mitochondrial phosphate-carrier deficiency: a novel disorder of oxidative phosphorylation. Am J Hum Genet 2007, 80:478-484.
20. Mayr J.A., Zimmermann F.A., Horváth R., Schneider H.-C., Schoser B., Holinski-Feder E., et al. Deficiency of the mitochondrial phosphate carrier presenting as myopathy and cardiomyopathy in a family with three affected children. Neuromuscul Disord 2011, 21:803-808.
21. Dickins R.A., McJunkin K., Hernando E., Premsrirut P.K., Krizhanovsky V., Burgess D.J., et al. Tissue-specific and reversible RNA interference in transgenic mice. Nat Genet 2007, 39:914-921.
22. Sanbe A., Gulick J., Hanks M.C., Liang Q., Osinska H., Robbins J. Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res 2003, 92:609-616.
23. Baines C.P., Kaiser R.A., Sheiko T., Craigen W.J., Molkentin J.D. Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 2007, 9:550-555.
24. Roy A., Kucukural A., Zhang Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 2010, 5:725-738.
25. Chaudhury S., Gray J.J. Conformer selection and induced fit in flexible backbone protein-protein docking using computational and NMR ensembles. J Mol Biol 2008, 381:1068-1087.
26. Schrodinger L.L.C. The PyMOL molecular graphics system, version 1.3r1 2010.
27. Davis T.L., Walker J.R., Campagna-Slater V., Finerty P.J., Paramanathan R., Bernstein G., et al. Structural and biochemical characterization of the human cyclophilin family of peptidyl-prolyl isomerases. PLoS Biol 2010, 10.1371/journal.pbio.1000439.
28. Varanyuwatana P., Halestrap A.P. The roles of phosphate and the phosphate carrier in the mitochondrial permeability transition pore. Mitochondrion 2011, 12:120-125.
29. Brand M.D., Nicholls D.G. Assessing mitochondrial dysfunction in cells. Biochem J 2011, 435:297-312.
30. Di Lisa F., Bernardi P. Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole. Cardiovasc Res 2006, 70:191-199.
31. Nguyen T.T., Stevens M.V., Kohr M., Steenbergen C., Sack M.N., Murphy E. Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J Biol Chem 2011, 286:40184-40192.
32. Gutiérrez-Aguilar M., Baines C.P. Physiological and pathological roles of mitochondrial SLC25 carriers. Biochem J 2013, 454:371-386.
33. Long R., Salouage I., Berdeaux A., Motterlini R., Morin D. CORM-3, a water soluble CO-releasing molecule, uncouples mitochondrial respiration via interaction with the phosphate carrier. Biochim Biophys Acta 1837, 2013:201-209.
34. Cleland J.G., Oakley C.M. Vascular tone in heart failure: the neuroendocrine-therapeutic interface. Br Heart J 1991, 66:264-267.
35. Gutiérrez-Aguilar M., Pérez-Martínez X., Chávez E., Uribe-Carvajal S. In Saccharomyces cerevisiae, the phosphate carrier is a component of the mitochondrial unselective channel. Arch Biochem Biophys 2010, 494:184-191.
36. Bernardi P. The mitochondrial permeability transition pore: a mystery solved?. Front Physiol 2013, 10.3389/fphys.2013.00095.
37. 2+. Biochemistry 1996, 35:8483-8488.
38. Szabò I., De Pinto V., Zoratti M. The mitochondrial permeability transition pore may comprise VDAC molecules. II. The electrophysiological properties of VDAC are compatible with those of the mitochondrial megachannel. FEBS Lett 1993, 330:206-210.
39. Zoratti M., De Marchi U., Biasutto L., Szabò I. Electrophysiology clarifies the megariddles of the mitochondrial permeability transition pore. FEBS Lett 2010, 584:1997-2004.
40. Kwong J.Q., Davis J., Baines C.P., Sargent M.A., Karch J., Wang X., et al. Deletion of the mitochondrial phosphate carrier desensitizes the mitochondrial permeability transition pore and causes cardiomyopathy. Cell Death Differ 2014, [in press]. 10.1038/cdd.2014.36.